PMC:7502678 / 25893-27890 JSON TXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T135","span":{"begin":698,"end":701},"obj":"Disease"}],"attributes":[{"id":"A135","pred":"mondo_id","subj":"T135","obj":"http://purl.obolibrary.org/obo/MONDO_0043219"}],"text":"Acknowledgments\nThe authors would like to acknowledge the members of the AES Q-PULSE Task Force who created the survey instrument: Nicholas Beimer, MD; Mesha-Gay Brown, MD; Brian T. Cabaniss, MD; Cristina Y. Go, MD; Kyung-Wha Kim, MD; Katherine Noe, MD, PhD; Imran H. Quraishi, MD, PhD; Tung Tran, MD; Daniel Winkel, MD. The authors would also like to acknowledge the members of the AES Guidelines and Assessments Committee and Council on Clinical Activities who reviewed this manuscript: Naoki Akamatsu, MD, PhD; Christine Baca, MD; Michael Gelfand, MD, PhD; Emily L. Johnson, MD; Lisa V. Knopf, MD; Appaji Rayi, MD; John M. Stern, MD, MA; Elissa Yozawitz, MD; Barry Gidal, PharmD; Anup Patel MD, MBA; and Timothy Welty, PharmD. Finally, the authors would like to acknowledge Penny Dacks, PhD, AES Associate Executive Director, for her support for this project. Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article. J.N.A: Consultant for SK Lifescience. J.W.L: Cash compensation from Digitrace and Teladoc; grant from Enagage Therapeutics; co-founder of Soterya Inc. J.R.P: Stock ownership in Cognizance biomarkers, LLC. A.M.H: Editor for Journal of Clinical Neurophysiology; scientific advisory board or consultant for Marinus Pharmaceuticals, UCB Pharmaceuticals, Jazz Pharmaceuticals, Sage Therapeutics, Eisai Pharmaceuticals, and Neurelis Pharmaceuticals; royalties from Springer Publishers, Demos Medical Publishing, and Wolters Kluwer; research support from Marinus Pharmaceuticals, Sage Therapeutics, Biogen Idec, and UCB Pharmaceuticals.\nFunding: The author(s) received no financial support for the research, authorship, and/or publication of this article.\nORCID iD: Joy A. Keller https://orcid.org/0000-0002-1483-6859\nAatif M. Husain https://orcid.org/0000-0001-7954-1755\nSupplemental Material: Supplemental material for this article is available online."}

LitCovid-PD-CLO

LitCovid-PD-CHEBI

LitCovid-PubTator

{"project":"LitCovid-PubTator","denotations":[{"id":"473","span":{"begin":1420,"end":1424},"obj":"Gene"},{"id":"474","span":{"begin":1621,"end":1625},"obj":"Gene"},{"id":"475","span":{"begin":1319,"end":1333},"obj":"Disease"},{"id":"477","span":{"begin":1797,"end":1805},"obj":"Disease"}],"attributes":[{"id":"A473","pred":"tao:has_database_id","subj":"473","obj":"Gene:55511"},{"id":"A474","pred":"tao:has_database_id","subj":"474","obj":"Gene:55511"},{"id":"A477","pred":"tao:has_database_id","subj":"477","obj":"MESH:C535742"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Acknowledgments\nThe authors would like to acknowledge the members of the AES Q-PULSE Task Force who created the survey instrument: Nicholas Beimer, MD; Mesha-Gay Brown, MD; Brian T. Cabaniss, MD; Cristina Y. Go, MD; Kyung-Wha Kim, MD; Katherine Noe, MD, PhD; Imran H. Quraishi, MD, PhD; Tung Tran, MD; Daniel Winkel, MD. The authors would also like to acknowledge the members of the AES Guidelines and Assessments Committee and Council on Clinical Activities who reviewed this manuscript: Naoki Akamatsu, MD, PhD; Christine Baca, MD; Michael Gelfand, MD, PhD; Emily L. Johnson, MD; Lisa V. Knopf, MD; Appaji Rayi, MD; John M. Stern, MD, MA; Elissa Yozawitz, MD; Barry Gidal, PharmD; Anup Patel MD, MBA; and Timothy Welty, PharmD. Finally, the authors would like to acknowledge Penny Dacks, PhD, AES Associate Executive Director, for her support for this project. Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article. J.N.A: Consultant for SK Lifescience. J.W.L: Cash compensation from Digitrace and Teladoc; grant from Enagage Therapeutics; co-founder of Soterya Inc. J.R.P: Stock ownership in Cognizance biomarkers, LLC. A.M.H: Editor for Journal of Clinical Neurophysiology; scientific advisory board or consultant for Marinus Pharmaceuticals, UCB Pharmaceuticals, Jazz Pharmaceuticals, Sage Therapeutics, Eisai Pharmaceuticals, and Neurelis Pharmaceuticals; royalties from Springer Publishers, Demos Medical Publishing, and Wolters Kluwer; research support from Marinus Pharmaceuticals, Sage Therapeutics, Biogen Idec, and UCB Pharmaceuticals.\nFunding: The author(s) received no financial support for the research, authorship, and/or publication of this article.\nORCID iD: Joy A. Keller https://orcid.org/0000-0002-1483-6859\nAatif M. Husain https://orcid.org/0000-0001-7954-1755\nSupplemental Material: Supplemental material for this article is available online."}

LitCovid-sentences

PMC:7502678 / 25893-27890 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

LitCovid-PD-CLO

LitCovid-PD-CHEBI

LitCovid-PubTator

LitCovid-sentences

PMC:7502678 / 25893-27890 JSON TXT